Global Chronic Urticaria Or Hives Drug Market Insights, Forecast to 2025

2018-12-05 / 3900.00 / Pharma & Healthcare / 111 Pages

Description

In 2017, the global Chronic Urticaria Or Hives Drug market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Chronic Urticaria Or Hives Drug market based on company, product type, application and key regions.

This report studies the global market size of Chronic Urticaria Or Hives Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chronic Urticaria Or Hives Drug in these regions.
This research report categorizes the global Chronic Urticaria Or Hives Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Chronic Urticaria Or Hives Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Chronic Urticaria Or Hives Drug include
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited

Market Size Split by Type
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Market Size Split by Application
Clinic
Hospital
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Chronic Urticaria Or Hives Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Chronic Urticaria Or Hives Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Chronic Urticaria Or Hives Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chronic Urticaria Or Hives Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Chronic Urticaria Or Hives Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Chronic Urticaria Or Hives Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chronic Urticaria Or Hives Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Chronic Urticaria Or Hives Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Type
1.4.2 GDC-0853
1.4.3 GSK-2646264
1.4.4 BF-Derm-1
1.4.5 Bilastine
1.4.6 Others
1.5 Market by Application
1.5.1 Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Chronic Urticaria Or Hives Drug Market Size
2.1.1 Global Chronic Urticaria Or Hives Drug Revenue 2016-2025
2.1.2 Global Chronic Urticaria Or Hives Drug Sales 2016-2025
2.2 Chronic Urticaria Or Hives Drug Growth Rate by Regions
2.2.1 Global Chronic Urticaria Or Hives Drug Sales by Regions
2.2.2 Global Chronic Urticaria Or Hives Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Chronic Urticaria Or Hives Drug Sales by Manufacturers
3.1.1 Chronic Urticaria Or Hives Drug Sales by Manufacturers
3.1.2 Chronic Urticaria Or Hives Drug Sales Market Share by Manufacturers
3.1.3 Global Chronic Urticaria Or Hives Drug Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Urticaria Or Hives Drug Revenue by Manufacturers
3.2.1 Chronic Urticaria Or Hives Drug Revenue by Manufacturers (2016-2018)
3.2.2 Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers (2016-2018)
3.3 Chronic Urticaria Or Hives Drug Price by Manufacturers
3.4 Chronic Urticaria Or Hives Drug Manufacturing Base Distribution, Product Types
3.4.1 Chronic Urticaria Or Hives Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Urticaria Or Hives Drug Product Category
3.4.3 Date of International Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Chronic Urticaria Or Hives Drug Sales by Type
4.2 Global Chronic Urticaria Or Hives Drug Revenue by Type
4.3 Chronic Urticaria Or Hives Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Chronic Urticaria Or Hives Drug Breakdown Data by Application

6 North America
6.1 North America Chronic Urticaria Or Hives Drug by Countries
6.1.1 North America Chronic Urticaria Or Hives Drug Sales by Countries
6.1.2 North America Chronic Urticaria Or Hives Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Chronic Urticaria Or Hives Drug by Type
6.3 North America Chronic Urticaria Or Hives Drug by Application
6.4 North America Chronic Urticaria Or Hives Drug by Company

7 Europe
7.1 Europe Chronic Urticaria Or Hives Drug by Countries
7.1.1 Europe Chronic Urticaria Or Hives Drug Sales by Countries
7.1.2 Europe Chronic Urticaria Or Hives Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chronic Urticaria Or Hives Drug by Type
7.3 Europe Chronic Urticaria Or Hives Drug by Application
7.4 Europe Chronic Urticaria Or Hives Drug by Company

8 Asia Pacific
8.1 Asia Pacific Chronic Urticaria Or Hives Drug by Countries
8.1.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales by Countries
8.1.2 Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Chronic Urticaria Or Hives Drug by Type
8.3 Asia Pacific Chronic Urticaria Or Hives Drug by Application
8.4 Asia Pacific Chronic Urticaria Or Hives Drug by Company

9 Central & South America
9.1 Central & South America Chronic Urticaria Or Hives Drug by Countries
9.1.1 Central & South America Chronic Urticaria Or Hives Drug Sales by Countries
9.1.2 Central & South America Chronic Urticaria Or Hives Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Chronic Urticaria Or Hives Drug by Type
9.3 Central & South America Chronic Urticaria Or Hives Drug by Application
9.4 Central & South America Chronic Urticaria Or Hives Drug by Company

10 Middle East and Africa
10.1 Middle East and Africa Chronic Urticaria Or Hives Drug by Countries
10.1.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Countries
10.1.2 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Chronic Urticaria Or Hives Drug by Type
10.3 Middle East and Africa Chronic Urticaria Or Hives Drug by Application
10.4 Middle East and Africa Chronic Urticaria Or Hives Drug by Company

11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.1.4 Chronic Urticaria Or Hives Drug Product Description
11.1.5 Recent Development
11.2 Biofrontera AG
11.2.1 Biofrontera AG Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.2.4 Chronic Urticaria Or Hives Drug Product Description
11.2.5 Recent Development
11.3 ELORAC, Inc.
11.3.1 ELORAC, Inc. Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.3.4 Chronic Urticaria Or Hives Drug Product Description
11.3.5 Recent Development
11.4 Faes Farma, SA
11.4.1 Faes Farma, SA Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.4.4 Chronic Urticaria Or Hives Drug Product Description
11.4.5 Recent Development
11.5 Genentech, Inc.
11.5.1 Genentech, Inc. Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.5.4 Chronic Urticaria Or Hives Drug Product Description
11.5.5 Recent Development
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.6.4 Chronic Urticaria Or Hives Drug Product Description
11.6.5 Recent Development
11.7 J Uriach Y Compania, S.A.
11.7.1 J Uriach Y Compania, S.A. Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.7.4 Chronic Urticaria Or Hives Drug Product Description
11.7.5 Recent Development
11.8 Mabtech Limited
11.8.1 Mabtech Limited Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.8.4 Chronic Urticaria Or Hives Drug Product Description
11.8.5 Recent Development
11.9 Merck & Co., Inc.
11.9.1 Merck & Co., Inc. Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.9.4 Chronic Urticaria Or Hives Drug Product Description
11.9.5 Recent Development
11.10 Mycenax Biotech Inc.
11.10.1 Mycenax Biotech Inc. Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Chronic Urticaria Or Hives Drug
11.10.4 Chronic Urticaria Or Hives Drug Product Description
11.10.5 Recent Development
11.11 Novartis AG
11.12 Panacea Biotec Limited

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Chronic Urticaria Or Hives Drug Raw Material
13.1.2 Chronic Urticaria Or Hives Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Picture of Chronic Urticaria Or Hives Drug
Figure Global Chronic Urticaria Or Hives Drug Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Chronic Urticaria Or Hives Drug Production Market Share by Types (Product Category) in 2017
Figure GDC-0853 Product Picture
Table Major Manufacturers of GDC-0853
Figure GSK-2646264 Product Picture
Table Major Manufacturers of GSK-2646264
Figure BF-Derm-1 Product Picture
Table Major Manufacturers of BF-Derm-1
Figure Bilastine Product Picture
Table Major Manufacturers of Bilastine
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Chronic Urticaria Or Hives Drug Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Clinic
Figure Hospital
Figure Others
Figure Chronic Urticaria Or Hives Drug Report Years Considered
Figure Global Chronic Urticaria Or Hives Drug Market Size 2016-2025 (Million US$)
Figure Global Chronic Urticaria Or Hives Drug Sales 2016-2025 (K Pcs)
Table Global Chronic Urticaria Or Hives Drug Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Chronic Urticaria Or Hives Drug Sales by Regions 2016-2025 (K Pcs)
Table Global Chronic Urticaria Or Hives Drug Sales Market Share by Regions 2016-2025
Figure Global Chronic Urticaria Or Hives Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Chronic Urticaria Or Hives Drug Sales Market Share by Regions
Table Global Chronic Urticaria Or Hives Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Chronic Urticaria Or Hives Drug Revenue Market Share by Regions 2016-2025
Figure Global Chronic Urticaria Or Hives Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Chronic Urticaria Or Hives Drug Revenue Market Share by Regions
Table Global Chronic Urticaria Or Hives Drug Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Chronic Urticaria Or Hives Drug Sales Share by Manufacturers (2016-2018)
Figure Global Chronic Urticaria Or Hives Drug Sales Share by Manufacturers in 2017
Table Chronic Urticaria Or Hives Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Chronic Urticaria Or Hives Drug Revenue Share by Manufacturers (2016-2018)
Figure Chronic Urticaria Or Hives Drug Value Share by Manufacturers in 2017
Table Global Chronic Urticaria Or Hives Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Chronic Urticaria Or Hives Drug Price (2016-2018) (USD/Pcs)
Table Chronic Urticaria Or Hives Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Chronic Urticaria Or Hives Drug Product Category
Table Date of International Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Chronic Urticaria Or Hives Drug Sales by Type (2016-2025) (K Pcs)
Table Global Chronic Urticaria Or Hives Drug Sales Share by Type (2016-2025)
Figure Global Chronic Urticaria Or Hives Drug Sales Market Share by Type (2016-2025)
Figure Global Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2017
Table Global Chronic Urticaria Or Hives Drug Revenue by Type (2016-2025) (Million US$)
Table Global Chronic Urticaria Or Hives Drug Revenue Share by Type (2016-2025)
Figure Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type (2016-2025)
Figure Global Chronic Urticaria Or Hives Drug Revenue Market Share by Type in 2017
Table Chronic Urticaria Or Hives Drug Price by Type 2013-2018 (USD/Pcs)
Table Global Chronic Urticaria Or Hives Drug Sales by Application (2016-2025) (K Pcs)
Table Global Chronic Urticaria Or Hives Drug Sales Share by Application (2016-2025)
Figure Global Sales Chronic Urticaria Or Hives Drug Market Share by Application (2016-2025)
Figure Global Sales Chronic Urticaria Or Hives Drug Market Share by Application (2016-2025)
Figure North America Chronic Urticaria Or Hives Drug Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Chronic Urticaria Or Hives Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Chronic Urticaria Or Hives Drug Sales by Countries (2016-2025) (K Pcs)
Table North America Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Chronic Urticaria Or Hives Drug Sales Market Share by Countries
Table North America Chronic Urticaria Or Hives Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Chronic Urticaria Or Hives Drug Revenue Market Share by Countries
Figure United States Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Chronic Urticaria Or Hives Drug Sales by Type (2016-2025) (K Pcs)
Table North America Chronic Urticaria Or Hives Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Chronic Urticaria Or Hives Drug Market Share by Type
Table North America Chronic Urticaria Or Hives Drug Sales by Application (2016-2025) (K Pcs)
Table North America Chronic Urticaria Or Hives Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Chronic Urticaria Or Hives Drug Market Share by Application
Table North America Chronic Urticaria Or Hives Drug Sales by Company (2016-2018) (K Pcs)
Table North America Chronic Urticaria Or Hives Drug Sales Market Share by Company (2016-2018)
Figure North America Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2017
Figure Europe Chronic Urticaria Or Hives Drug Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Chronic Urticaria Or Hives Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Chronic Urticaria Or Hives Drug Sales by Countries (2016-2025) (K Pcs)
Table Europe Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Chronic Urticaria Or Hives Drug Sales Market Share by Countries
Table Europe Chronic Urticaria Or Hives Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Countries
Figure Germany Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure France Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Chronic Urticaria Or Hives Drug Sales by Type (2016-2025) (K Pcs)
Table Europe Chronic Urticaria Or Hives Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Chronic Urticaria Or Hives Drug Market Share by Type
Table Europe Chronic Urticaria Or Hives Drug Sales by Application (2016-2025) (K Pcs)
Table Europe Chronic Urticaria Or Hives Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Chronic Urticaria Or Hives Drug Market Share by Application
Table Europe Chronic Urticaria Or Hives Drug Sales by Company (2016-2018) (K Pcs)
Table Europe Chronic Urticaria Or Hives Drug Sales Market Share by Company (2016-2018)
Figure Europe Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2017
Figure Asia Pacific Chronic Urticaria Or Hives Drug Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Chronic Urticaria Or Hives Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Chronic Urticaria Or Hives Drug Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Countries
Table Asia Pacific Chronic Urticaria Or Hives Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Chronic Urticaria Or Hives Drug Revenue Market Share by Countries
Figure China Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure China Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure India Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Chronic Urticaria Or Hives Drug Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Chronic Urticaria Or Hives Drug Market Share by Type
Table Asia Pacific Chronic Urticaria Or Hives Drug Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Chronic Urticaria Or Hives Drug Market Share by Application
Table Asia Pacific Chronic Urticaria Or Hives Drug Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2017
Figure Central & South America Chronic Urticaria Or Hives Drug Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Chronic Urticaria Or Hives Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Chronic Urticaria Or Hives Drug Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Chronic Urticaria Or Hives Drug Sales Market Share by Countries
Table Central & South America Chronic Urticaria Or Hives Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Chronic Urticaria Or Hives Drug Revenue Market Share by Countries
Figure Brazil Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Chronic Urticaria Or Hives Drug Sales by Type (2016-2025) (K Pcs)
Table Central & South America Chronic Urticaria Or Hives Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Chronic Urticaria Or Hives Drug Market Share by Type
Table Central & South America Chronic Urticaria Or Hives Drug Sales by Application (2016-2025) (K Pcs)
Table Central & South America Chronic Urticaria Or Hives Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Chronic Urticaria Or Hives Drug Market Share by Application
Table Central & South America Chronic Urticaria Or Hives Drug Sales by Company (2016-2018) (K Pcs)
Table Central & South America Chronic Urticaria Or Hives Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Chronic Urticaria Or Hives Drug Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Chronic Urticaria Or Hives Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Countries
Table Middle East and Africa Chronic Urticaria Or Hives Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Countries
Figure GCC Countries Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Chronic Urticaria Or Hives Drug Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Chronic Urticaria Or Hives Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Chronic Urticaria Or Hives Drug Market Share by Type
Table Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Chronic Urticaria Or Hives Drug Market Share by Application
Table Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Company in 2017
Table AstraZeneca Plc Company Details
Table AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table AstraZeneca Plc Recent Development
Table Biofrontera AG Company Details
Table Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Biofrontera AG Recent Development
Table ELORAC, Inc. Company Details
Table ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table ELORAC, Inc. Recent Development
Table Faes Farma, SA Company Details
Table Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Faes Farma, SA Recent Development
Table Genentech, Inc. Company Details
Table Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Genentech, Inc. Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table GlaxoSmithKline Plc Recent Development
Table J Uriach Y Compania, S.A. Company Details
Table J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table J Uriach Y Compania, S.A. Recent Development
Table Mabtech Limited Company Details
Table Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Mabtech Limited Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Merck & Co., Inc. Recent Development
Table Mycenax Biotech Inc. Company Details
Table Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Mycenax Biotech Inc. Recent Development
Table Novartis AG Company Details
Table Panacea Biotec Limited Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Chronic Urticaria Or Hives Drug Value Chain
Table Typical Suppliers of Key Chronic Urticaria Or Hives Drug Raw Material
Table Chronic Urticaria Or Hives Drug Customers List
Table Chronic Urticaria Or Hives Drug Sales Channels
Table Chronic Urticaria Or Hives Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory